2026-10-25
Freeport-McMoRan clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 29,403 −1.38%
S&P 7,720 −0.30%
GOLD $4,011 −1.01%
BTC $76,498 −5.87%
VIX 17.20 +1.71%
latest tape · as of 02:02 UTC
The Screen · Basic Materials · Copper
Freeport-McMoRan
FCX · a US exchange · USD · Market cap $95.0B · 29,000 employees
Freeport-McMoRan Inc.
Not yet scored66.14 USD
Price as of 29 Oct 2026Daily close, not a live quote
Screened 2026-10-29 · the tape above runs as of 02:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price66.14 USD at the 29 Oct 2026 close
- Our ratingQuality, fully valued, current read markdown
- Ethical screenNot yet scored
- OptionsOpen interest leans slightly to calls (put/call 0.94)
- Last reviewed29 Oct 2026 (1 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 66.14 against the desk's fair-value range, base estimate 59.10, over the last year.
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 0.94, read 2026-10-29
- Ethical screen not yet scored
Price66.14 USD
Fair value59.10
Ethical score91.0/100
RatingQUALITY, FULLY VALUED
Our investment reviews on this name
2026-10-18Read Markdown70.06-5.6% to today ✓Accumulation gives way to Markdown first Markdown read since October
2026-10-11Read Accumulation72.31-8.5% to today Markdown gives way to Accumulation
2026-10-02Read Markdown72.31-8.5% to today ✓Markup gives way to Markdown
2026-08-23Read Markup71.22-7.1% to today Distribution gives way to Markup after a 22% rise in 5 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its markdown label.
Freeport-McMoRan holds its Markdown at $66.14. Consolidating, no directional conviction, held for 24 days.
| Phase | Markdown · caution |
| Quantitative state | Consolidating, no directional conviction, held for 24 days |
| Price at the screen | $66.14 |
| Valuation | 27.79 trailing · 15.23 forward price to earnings |
| Values screen | Not scored · score 91.0 |
| Beta | 1.39 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 18.04% | Below 33% | Interest-bearing debt is just 18.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.21% | Below 33% | Cash held in interest-bearing accounts and securities is 0.2% of assets, under the one-third limit. | Pass |
| Receivables | 8.25% | Below 49% | Money owed to the company is 8.3% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Freeport-McMoRan clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Freeport-McMoRan clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 18%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads QUALITY, FULLY VALUED: it trades above our $59.10 fair value estimate, moderate competitive moat, 8.20% revenue growth.
Fair value range in USD, drawn from the 2026-10-29 screen. The gold marker is the market price at the same screen. The price runs 10.6% above the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +23% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-29 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCopper miner priced for endless boom times
Picture a digger hauling ore while prices surge, only to watch the market already bake in permanent highs. Freeport-McMoRan sits in that exact spot. Our numbers place it seven percent above fair value, so the shares offer no margin of safety despite the moderate moat and clean ethical screen.
Forward earnings sit at fourteen point five times while revenue grows nine percent and returns on equity reach sixteen percent. Profit margins of ten percent look respectable, yet in copper those figures often mark the top of the cycle rather than a bargain. Twenty two analysts still push a buy with a seventy four dollar median target, but that optimism ignores how peak earnings can flatten multiples without any drop in the share price.
The real risk sits in commodity swings and capital intensity that can turn a modest premium into lasting underperformance. Low multiples in cyclical miners usually signal warning, not opportunity. Analysis, not advice.
| Forward P/E | 15.2xpriced for continued growth |
| Trailing P/E | 27.8xa premium valuation |
| EPS, trailing | 2.38 |
| EPS, forward | 4.34 |
| Revenue growth | +8.2%steady growth |
| Profit margin | 13.0%thin but positive margins |
| Return on equity | 15.7%a solid return on shareholder capital |
| FCF yield | 1.97% |
| Dividend yield | 0.91% |
| Debt to equity | 0.31minimal debt: a conservative balance sheet |
| Current ratio | 2.02comfortably covers its short-term bills |
| Beta | 1.39moves a little more than the market |
| Short interest, float | 0.02% |
| 52-week range | 38.54 - 80.24 |
| Moat | MODERATE |
| Market cap | $95.0B |
| Employees | 29,000 |
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeFCX trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-27
Markdown $70.06
+0.0% Entry 21
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26
Markdown $70.06
+0.0% Entry 20
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25
Markdown $70.06
+0.0% Entry 19
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24
Markdown $70.06
+0.0% Entry 18
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23
Markdown $70.06
+0.0% Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22
Markdown $70.06
+0.0% Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Markdown $70.06
+0.0% Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20
Markdown $70.06
+0.0% Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 8% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18
Markdown · changed $70.06
-3.1% Entry 13
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.1% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68.
2026-10-11
Accumulation · changed $72.31
+0.0% Entry 12
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 24% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 49%. Our forward projection puts the odds of a 10% gain over the next month near 28%. The street (22 analysts) rates it buy, with a mean price target of $68.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- What Could Lift Newmont Stock? Yahoo Finance · 7h ago
- Freeport McMoRan (FCX) Stock Faces Q3 Earnings Valuation Questions Yahoo Finance · 1d ago
- What Is The One Risk Every Newmont Investor Should Know? Yahoo Finance · 1d ago
- FCX Q3 Earnings Call Highlights Grasberg Recovery and Growth Plans Yahoo Finance · 2d ago
- Company News for Oct 28, 2026 Yahoo Finance · 2d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
SCCOSouthern Copper Corp
HBMHudbay Minerals Inc
EROEro Copper Corp.
TGBTaseko Mines Limited
IEIvanhoe Electric Inc.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-01 | STEPHENS JOHN JOSEPH | Director | 350 | $20,573 | |
| 2026-04-01 | GRANT HUGH N | Director | 574 | $33,740 | |
| 2026-03-06 | ADKERSON RICHARD C | Chairman of the Board | 27,693 | · | |
| 2026-02-20 | HIGGINS STEPHEN T | Officer | 29,654 | $1,868,202 | |
| 2026-02-18 | MIKES ELLIE L. | Officer | 11,000 | $682,345 | |
| 2026-02-13 | ROBERTSON MAREE E | Chief Financial Officer | 48,500 | $2,985,175 | |
| 2026-02-11 | CURRAULT DOUGLAS NICHOLAS II | General Counsel | 75,000 | $892,250 | |
| 2026-02-11 | CURRAULT DOUGLAS NICHOLAS II | General Counsel | 75,000 | $4,838,812 | |
| 2026-02-11 | ADKERSON RICHARD C | Chairman of the Board | 400,991 | $25,464,329 | |
| 2026-02-10 | ROBERTSON MAREE E | Chief Financial Officer | 43,875 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-08-10 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-10 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-10 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-10 | Ro Khanna | Democrat | sell | 1K–15K |
| 2026-08-10 | Ro Khanna | Democrat | sell | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $64.37 | -3.2% | · | $969 | -3.2% |
| 2 months | $67.65 | -7.8% | $0.15 | $924 | -7.6% |
| 3 months | $59.08 | +5.5% | $0.15 | $1,058 | +5.8% |
| 6 months | $47.88 | +30.2% | $0.30 | $1,308 | +30.8% |
| 1 year | $41.71 | +49.5% | $0.60 | $1,509 | +50.9% |
| 2 years | $48.73 | +28.0% | $1.20 | $1,304 | +30.4% |
| 3 years | $36.40 | +71.3% | $1.80 | $1,762 | +76.2% |
| 5 years | $38.14 | +63.5% | $2.85 | $1,709 | +70.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever FCX does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.